297
Participants
Start Date
November 20, 2017
Primary Completion Date
February 14, 2019
Study Completion Date
February 14, 2019
Placebo
Placebo was administered once daily
400mg SPN-812
400mg SPN-812 was administered once daily and compared to Placebo
600mg SPN-812
600mg SPN-812 was administered once daily and compared to Placebo
Carolina Clinical Trials, Inc., Charleston
iResearch Atlanta, Decatur
APG Research, LLC, Orlando
Miami Clinical Research, Miami
Innovative Clinical Research, Inc, Lauderhill
Meridien Research at Florida Clinical Research Center, Bradenton
IPS Research, Oklahoma City
Paradigm Research Professionals, Oklahoma City
Bayou City Research Corporation, Houston
Discovery MM Services Inc. Houston, Houston
Gadolin Research, LLC, Beaumont
MCB Clinical Research Centers, LLC, Colorado Springs
Ericksen Research & Development, Clinton
Alliance for Wellness dba Alliance for Research, Long Beach
Supernus Pharmaceuticals, Inc.
INDUSTRY